Online lifestyle program with an AI coach and glucose monitoring for type 2 diabetes
Tests an online lifestyle program with an AI coach in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.
Key facts
- Where
- Enschede, NetherlandsSee the site
Where in Netherlands
- University of TwenteEnschede, NetherlandsNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Twente
- Trial code
- NCT07661381
- Record updated
- 25 June 2026
- Original description
The aim of this study is to evaluate the feasibility and effectiveness of a remote personalised lifestyle program in individuals with T2D. Outcomes will be assessed at the start and after 3, 6, and 12 months with two follow-up measurements (18 and 24 months) to determine whether participation in this re-mote lifestyle program leads to improvements in health and diabetes-related outcomes.Read full original descriptionShow less
"An Online Personalised Lifestyle Program With a Virtual AI Lifestyle Coach in Combination With Continues Glucose Monitoring for People With Type 2 Diabetes."
The aim of this study is to evaluate the feasibility and effectiveness of a remote personalised lifestyle program in individuals with T2D. Outcomes will be assessed at the start and after 3, 6, and 12 months with two follow-up measurements (18 and 24 months) to determine whether participation in this re-mote lifestyle program leads to improvements in health and diabetes-related outcomes.
Inclusion: Age: ≥18 years; HbA1c: ≥53 mmol/mol (7 - 12%); Signed informed consent form and willing to comply with the study procedures; Persons who are naïve for participation in a lifestyle program for the past two years; Being digitally competent; Mastering the Dutch language; Accepting the confidential use and storage of anonymised data for analysis and publication (at least 15 years).
Exclusion: Unstable body weight in the three months prior to inclusion in the study (±5% change based on body weight); Comorbidities or medical conditions requiring a special diet that conflicts with the study; Medication use: any other glucose-lowering medication than metformin; Circumstances that lead to unreliable HbA1c values, such as blood donation; Pregnant or lactating women.